Table 2.
SPT with dog allergen (n = 424) |
P-value∗ | SPT with cat allergen (n = 305) |
P-value∗ | |||
---|---|---|---|---|---|---|
Symptomatic groupa (n = 89) | Non-symptomatic group (n = 335) | Symptomatic groupa (n = 205) | Non-Symptomatic group (n = 100) | |||
MWD, mm | ||||||
Product (A) | 1.1 ± 1.6 | 0.6 ± 1.3 | 0.010 | 2.7 ± 2.8 | 1.0 ± 1.9 | < 0.001 |
Product (B) | 0.9 ± 1.7 | 0.5 ± 1.3 | 0.061 | 1.4 ± 1.9 | 0.6 ± 1.4 | < 0.001 |
Product (C) | 1.7 ± 2.2 | 1.2 ± 1.8 | 0.043 | 3.1 ± 3.1 | 1.4 ± 2.3 | < 0.001 |
A/H ratio | ||||||
Product (A) | 0.3 ± 0.6 | 0.1 ± 0.3 | 0.008 | 0.6 ± 0.7 | 0.2 ± 0.6 | < 0.001 |
Product (B) | 0.2 ± 0.6 | 0.1 ± 0.3 | 0.018 | 0.2 ± 0.4 | 0.1 ± 0.3 | 0.004 |
Product (C) | 0.6 ± 0.9 | 0.3 ± 0.5 | 0.003 | 0.8 ± 0.9 | 0.3 ± 0.6 | < 0.001 |
Positivity, % | ||||||
Positive if any wheal observed | ||||||
Product (A) | 29 (32.6) | 60 (17.9) | 0.003 | 57 (57.0) | 52 (25.4) | < 0.001 |
Product (B) | 24 (27.0) | 54 (16.1) | 0.019 | 41 (41.0) | 34 (16.6) | < 0.001 |
Product (C) | 41 (46.1) | 123 (36.7) | 0.107 | 60 (60.0) | 72 (35.1) | < 0.001 |
Positive if MHD ≥3 mm | ||||||
Product (A) | 23 (25.8) | 42 (12.5) | 0.002 | 48 (48.0) | 44 (21.5) | < 0.001 |
Product (B) | 15 (16.9) | 39 (11.6) | 0.190 | 30 (30.0) | 26 (12.7) | < 0.001 |
Product (C) | 29 (32.6) | 82 (24.5) | 0.122 | 55 (55.0) | 55 (26.8) | < 0.001 |
Positive if A/H ratio ≥1 | ||||||
Product (A) | 8 (9.0) | 13 (3.9) | 0.057 | 26 (26.0) | 16 (7.8) | < 0.001 |
Product (B) | 8 (9.0) | 12 (3.6) | 0.046 | 10 (10.0) | 6 (2.9) | 0.009 |
Product (C) | 25 (28.1) | 43 (12.8) | <0.001 | 34 (34.0) | 27 (13.2) | < 0.001 |
Data are shown as mean ± SD or frequency (%).
∗P-value < 0.05 is shown as boldface in comparing variables between subjects with allergic symptoms on dog exposure and those without it or between subjects with allergic symptoms on cat exposure and those without it. SPT, SPT, skin prick test; MWD, mean wheal diameter provoked by allergen in skin prick test; A/H ratio, allergen-to-histamine mean wheal diameter ratio.
Subjects who experienced symptoms of allergic rhinitis, allergic conjunctivitis, skin allergy, asthma, and cough during exposure to dog or cat